Progenics Pharmaceuticals Inc.

Progenics Pharmaceuticals is an oncology company focused on the development and commercialization of medicines and artificial intelligence to find, fight and follow cancer. The company's product candidates include: AZEDRA, which is a radiotherapeutic for the treatment of adult and pediatric patients 12 years and older with iobenguane scan positive or metastatic pheochromocytoma or paraganglioma who require systemic anticancer therapy; and PyL?, which is a fluorinated prostate-specific membrane antigen-targeted PET imaging agent that enables visualization of both bone and soft tissue metastases to determine the presence or absence of recurrent and/or metastatic prostate cancer.
  • TickerPGNX
  • ISINUS7431871067
  • CountryUnited States
Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • A number of Energy related names are reversing price and RS downtrends. (ex. DRQ, OII, AROC, and CKH) • A few banks and asset managers are inflecting positively or within uptrends. (ex. C, BRKL, VLY, FCF, LM, and INTL) • The healthcare Sector has a number of names inflecting bullishly (ex. CUTR, CMD, IART, CCRN, CRVL, MGLN, PGNX, ANIK, ILMN, IQV, and ANIP)

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • The Staples Sector is leadership and many names are staging price and RS reversals. • REIT's are breaking above bases and are showing RS leadership. • Paper & Forest products are strengthening and many are reversing price and RS downtrend or breaking above bases. • Large-Cap Pharma stocks are showing leadership. Many have broken topside of multi-year consolidations or have reversed multi-year price and RS downtrends.

Dave Nicoski ...
  • Ross LaDuke

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

Jonathan Moreland

InsiderInsights Daily Ratings Report: September 11, 2019

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland

InsiderInsights Daily Ratings Report: September 9, 2019

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

ResearchPool Subscriptions

Get the most out of your insights

Get in touch